Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

Nanomedicine is a burgeoning industry but an understanding of the interaction of nanomaterials with the immune system is critical for clinical translation. Macrophages play a fundamental role in the immune system by engulfing foreign particulates such as nanoparticles. When activated, macrophages form distinct phenotypic populations with unique immune functions, however the mechanism by which these polarized macrophages react to nanoparticles is unclear. Furthermore, strategies to selectively evade activated macrophage subpopulations are lacking. Here we demonstrate that stimulated macrophages possess higher phagocytic activities and that classically activated (M1) macrophages exhibit greater phagocytic capacity than alternatively activated (M2) macrophages. We show that modification of nanoparticles with polyethylene-glycol results in decreased clearance by all macrophage phenotypes, but importantly, coating nanoparticles with CD47 preferentially lowers phagocytic activity by the M1 phenotype. These results suggest that bio-inspired nanoparticle surface design may enable evasion of specific components of the immune system and provide a rational approach for developing immune tolerant nanomedicines.

[1]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[2]  H. Colten,et al.  gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. , 1985, The Journal of biological chemistry.

[3]  M. Mcgarry,et al.  Murine Eosinophil Granulocytes Bind the Murine Macrophage‐Monocyte Specific Monoclonal Antibody F4/80 , 1991, Journal of leukocyte biology.

[4]  Wen Jiang,et al.  Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles. , 2015, ACS nano.

[5]  Dennis E. Discher,et al.  Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells , 2008, The Journal of cell biology.

[6]  David M. Mosser,et al.  Activation of Murine Macrophages , 2008 .

[7]  E. Brown,et al.  Integrin-associated protein (CD47) and its ligands. , 2001, Trends in cell biology.

[8]  Katharina Landfester,et al.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.

[9]  P. Grimbert,et al.  Thrombospondin/CD47 Interaction: A Pathway to Generate Regulatory T Cells from Human CD4+CD25− T Cells in Response to Inflammation1 , 2006, The Journal of Immunology.

[10]  James E Bear,et al.  Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. , 2013, The Journal of clinical investigation.

[11]  Andrzej S Pitek,et al.  Tuning of nanoparticle biological functionality through controlled surface chemistry and characterisation at the bioconjugated nanoparticle surface , 2015, Scientific Reports.

[12]  Hong-Yang Wang,et al.  LPS-induced down-regulation of signal regulatory protein α contributes to innate immune activation in macrophages , 2007, The Journal of experimental medicine.

[13]  A. Surprenant,et al.  Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates , 2009, The EMBO journal.

[14]  Dennis E Discher,et al.  Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties. , 2015, Current opinion in immunology.

[15]  H. Wilson Macrophages heterogeneity in atherosclerosis – implications for therapy , 2010, Journal of cellular and molecular medicine.

[16]  Katharina Landfester,et al.  Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. , 2011, ACS nano.

[17]  D. Wink,et al.  Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells. , 2008, Cancer research.

[18]  Jens-Peter Volkmer,et al.  Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies , 2013, Science.

[19]  A. Sica,et al.  Macrophage polarization comes of age. , 2005, Immunity.

[20]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[21]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[22]  T. Springer,et al.  Mac-1 antigen: quantitative expression in macrophage populations and tissues, and immunofluorescent localization in spleen. , 1982, Journal of immunology.

[23]  Andrew Emili,et al.  Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.

[24]  Hans C. Fischer,et al.  Design and characterization of lysine cross-linked mercapto-acid biocompatible quantum dots , 2006 .

[25]  Florence Gazeau,et al.  Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake. , 2012, ACS nano.

[26]  I. Mikhailenko,et al.  IL‐4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6‐dependent, homotypic mechanism: contribution of E‐cadherin , 2007, Journal of leukocyte biology.

[27]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[28]  Marco Prinz,et al.  Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease , 2014, Nature Reviews Neuroscience.

[29]  S. Grinstein,et al.  Scavenger receptors in homeostasis and immunity , 2013, Nature Reviews Immunology.

[30]  A. Ullrich,et al.  A family of proteins that inhibit signalling through tyrosine kinase receptors , 1997, Nature.

[31]  M. Little,et al.  High-throughput paraffin section in situ hybridization and dual immunohistochemistry on mouse tissues. , 2008, CSH protocols.

[32]  T. K. van den Berg,et al.  CD47 functions as a molecular switch for erythrocyte phagocytosis. , 2012, Blood.

[33]  D. Vaux,et al.  Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. , 1999, Journal of immunology.

[34]  H. Sterling,et al.  CD47, a Ligand for the Macrophage Fusion Receptor, Participates in Macrophage Multinucleation* , 2000, The Journal of Biological Chemistry.

[35]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[36]  Jens-Peter Volkmer,et al.  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors , 2012, Proceedings of the National Academy of Sciences.

[37]  A. Iwasaki,et al.  Regulation of Adaptive Immunity by the Innate Immune System , 2010, Science.

[38]  L. Rice,et al.  Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis , 2014, Arthritis Research & Therapy.

[39]  T. Wynn,et al.  Obstacles and opportunities for understanding macrophage polarization , 2011, Journal of leukocyte biology.

[40]  Xia Zhang,et al.  Activation of Murine Macrophages , 2008, Current protocols in immunology.

[41]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[42]  Tingting Wang,et al.  Modulation of macrophage phenotype by cell shape , 2013, Proceedings of the National Academy of Sciences.

[43]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[44]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[45]  R. Leak,et al.  Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia , 2012, Stroke.

[46]  Dennis E Discher,et al.  Minimal " Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles References and Notes , 2022 .

[47]  Yuan Zhang,et al.  Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration. , 2013, European journal of cancer.

[48]  M. Manchester,et al.  Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironments. , 2012, Biomacromolecules.

[49]  I. Weissman,et al.  CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis , 2009, Cell.

[50]  A. Kraegeloh,et al.  M2 polarization enhances silica nanoparticle uptake by macrophages , 2015, Front. Pharmacol..

[51]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[52]  B. Porse,et al.  Bone Marrow-Derived Macrophages (BMM): Isolation and Applications. , 2008, CSH protocols.

[53]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.